Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated:  2/15/2018
GSK Investigational Site
mi
from
Huntington Beach, CA
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated: 2/15/2018
GSK Investigational Site
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated:  2/15/2018
GSK Investigational Site
mi
from
Aventura, FL
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated: 2/15/2018
GSK Investigational Site
mi
from
Aventura, FL
Click here to add this to my saved trials
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated:  2/15/2018
GSK Investigational Site
mi
from
Clearwater, FL
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated: 2/15/2018
GSK Investigational Site
mi
from
Clearwater, FL
Click here to add this to my saved trials
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated:  2/15/2018
GSK Investigational Site
mi
from
Miami, FL
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated: 2/15/2018
GSK Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated:  2/15/2018
GSK Investigational Site
mi
from
Baltimore, MD
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated: 2/15/2018
GSK Investigational Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated:  2/15/2018
GSK Investigational Site
mi
from
North Dartmouth, MA
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated: 2/15/2018
GSK Investigational Site
mi
from
North Dartmouth, MA
Click here to add this to my saved trials
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated:  2/15/2018
GSK Investigational Site
mi
from
Plymouth, MN
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated: 2/15/2018
GSK Investigational Site
mi
from
Plymouth, MN
Click here to add this to my saved trials
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated:  2/15/2018
GSK Investigational Site
mi
from
Columbia, MO
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated: 2/15/2018
GSK Investigational Site
mi
from
Columbia, MO
Click here to add this to my saved trials
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated:  2/15/2018
GSK Investigational Site
mi
from
Rolla, MO
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated: 2/15/2018
GSK Investigational Site
mi
from
Rolla, MO
Click here to add this to my saved trials
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated:  2/15/2018
GSK Investigational Site
mi
from
Warrensburg, MO
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated: 2/15/2018
GSK Investigational Site
mi
from
Warrensburg, MO
Click here to add this to my saved trials
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated:  2/15/2018
GSK Investigational Site
mi
from
Charlotte, NC
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated: 2/15/2018
GSK Investigational Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated:  2/15/2018
GSK Investigational Site
mi
from
Raleigh, NC
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated: 2/15/2018
GSK Investigational Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated:  2/15/2018
GSK Investigational Site
mi
from
Canton, OH
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated: 2/15/2018
GSK Investigational Site
mi
from
Canton, OH
Click here to add this to my saved trials
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated:  2/15/2018
GSK Investigational Site
mi
from
Cincinnati, OH
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated: 2/15/2018
GSK Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated:  2/15/2018
GSK Investigational Site
mi
from
Oklahoma City, OK
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated: 2/15/2018
GSK Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated:  2/15/2018
GSK Investigational Site
mi
from
Medford, OR
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated: 2/15/2018
GSK Investigational Site
mi
from
Medford, OR
Click here to add this to my saved trials
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated:  2/15/2018
GSK Investigational Site
mi
from
Orangeburg, SC
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated: 2/15/2018
GSK Investigational Site
mi
from
Orangeburg, SC
Click here to add this to my saved trials
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated:  2/15/2018
GSK Investigational Site
mi
from
Spartanburg, SC
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated: 2/15/2018
GSK Investigational Site
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated:  2/15/2018
GSK Investigational Site
mi
from
San Antonio, TX
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated: 2/15/2018
GSK Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated:  2/15/2018
GSK Investigational Site
mi
from
Waco, TX
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated: 2/15/2018
GSK Investigational Site
mi
from
Waco, TX
Click here to add this to my saved trials
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated:  2/15/2018
GSK Investigational Site
mi
from
Saint Petersburg, FL
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
204980: An Open-label Study to Evaluate the Correct Use of Placebo ELLIPTA™ Dry Powder Inhaler (DPI) Compared to Placebo Metered Dose Inhalers (MDI) in Subjects With Moderate Persistent Asthma
Status: Enrolling
Updated: 2/15/2018
GSK Investigational Site
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy: A Systems Approach Phase 1 (ICAC-29)
Status: Enrolling
Updated:  2/16/2018
Children's Hospital Colorado
mi
from
Aurora, CO
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy: A Systems Approach Phase 1 (ICAC-29)
Status: Enrolling
Updated: 2/16/2018
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy: A Systems Approach Phase 1 (ICAC-29)
Status: Enrolling
Updated:  2/16/2018
Childrens National Medical Center
mi
from
Washington,
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy: A Systems Approach Phase 1 (ICAC-29)
Status: Enrolling
Updated: 2/16/2018
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy: A Systems Approach Phase 1 (ICAC-29)
Status: Enrolling
Updated:  2/16/2018
Ann & Robert Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy: A Systems Approach Phase 1 (ICAC-29)
Status: Enrolling
Updated: 2/16/2018
Ann & Robert Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy: A Systems Approach Phase 1 (ICAC-29)
Status: Enrolling
Updated:  2/16/2018
Boston University School of Medicine
mi
from
Boston, MA
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy: A Systems Approach Phase 1 (ICAC-29)
Status: Enrolling
Updated: 2/16/2018
Boston University School of Medicine
mi
from
Boston, MA
Click here to add this to my saved trials
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy: A Systems Approach Phase 1 (ICAC-29)
Status: Enrolling
Updated:  2/16/2018
Henry Ford Health System
mi
from
Detroit, MI
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy: A Systems Approach Phase 1 (ICAC-29)
Status: Enrolling
Updated: 2/16/2018
Henry Ford Health System
mi
from
Detroit, MI
Click here to add this to my saved trials
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy: A Systems Approach Phase 1 (ICAC-29)
Status: Enrolling
Updated:  2/16/2018
Columbia University Medical Center
mi
from
New York, NY
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy: A Systems Approach Phase 1 (ICAC-29)
Status: Enrolling
Updated: 2/16/2018
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy: A Systems Approach Phase 1 (ICAC-29)
Status: Enrolling
Updated:  2/16/2018
Cincinnati Children's Hospital
mi
from
Cincinnati, OH
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy: A Systems Approach Phase 1 (ICAC-29)
Status: Enrolling
Updated: 2/16/2018
Cincinnati Children's Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy: A Systems Approach Phase 1 (ICAC-29)
Status: Enrolling
Updated:  2/16/2018
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy: A Systems Approach Phase 1 (ICAC-29)
Status: Enrolling
Updated: 2/16/2018
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy: A Systems Approach Phase 1 (ICAC-29)
Status: Enrolling
Updated:  2/16/2018
St. Louis Children's Hospital
mi
from
Saint Louis, MO
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy: A Systems Approach Phase 1 (ICAC-29)
Status: Enrolling
Updated: 2/16/2018
St. Louis Children's Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Pharmacogenetics of b2-Agonists in Asthma.
Pharmacogenetics of b2-Agonists in Asthma.
Status: Enrolling
Updated:  2/20/2018
Nemours Children's Clinic
mi
from
Jacksonville, FL
Pharmacogenetics of b2-Agonists in Asthma.
Pharmacogenetics of b2-Agonists in Asthma.
Status: Enrolling
Updated: 2/20/2018
Nemours Children's Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Study on the Role of Treatment With Vitamin E on Asthmatic Responses in Allergic Asthmatics
Oxidant Stress and Allergic Asthma
Status: Enrolling
Updated:  3/2/2018
Dep. of Medicine, Div. of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University
mi
from
Nashville, TN
Study on the Role of Treatment With Vitamin E on Asthmatic Responses in Allergic Asthmatics
Oxidant Stress and Allergic Asthma
Status: Enrolling
Updated: 3/2/2018
Dep. of Medicine, Div. of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Montgomery, AL
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Montgomery, AL
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Burbank, CA
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Burbank, CA
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Greenbrae, CA
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Greenbrae, CA
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Clearwater, FL
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Clearwater, FL
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Hollywood, FL
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Hollywood, FL
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Jacksonville, FL
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
New Port Richey, FL
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
New Port Richey, FL
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Ocala, FL
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Ocala, FL
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
West Palm Beach, FL
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Belvidere, IL
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Belvidere, IL
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Chicago, IL
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Springfield, IL
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Springfield, IL
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Topeka, KA
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Topeka, KA
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Louisville, KY
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Baltimore, MD
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Brockton, MA
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Brockton, MA
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Omaha, NE
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Las Vegas, NV
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials